Industry News-Good Doctor

Blog

——

Corporate News

Industry News

Hyperthermic Perfusion Podcast

Notice & Announcement

2018.11.22

Breaking! Large clinical study confirms the "killing power" of hyperthermic intraperitoneal chemotherapy on tumors.

In recent years, the incidence of malignant tumors in the abdominal cavity in our country, such as gastric cancer, colorectal cancer, and ovarian cancer, has shown a significant upward trend. Most cases are diagnosed at an advanced stage, and postoperative peritoneal implantation metastasis is a global challenge.

2018.11.22

Everything for the Health of the People - A Review of the Achievements of Medical and Health System Reform Since the 18th National Congress of the Communist Party

Since the 18th National Congress of the Communist Party, the Central Committee of the Party with Comrade Xi Jinping at its core has started a new journey to build a healthy China, based on the long-term development of the country and aiming for the great rejuvenation of the nation.

2018.11.19

Characteristics and Reasons for Mergers and Acquisitions in the Global Medical Device Industry

In recent years, the global medical device industry has shown three major characteristics in mergers and acquisitions: 1) becoming larger and larger, leading to increasing concentration, with fewer and fewer potential acquisition targets.

2018.11.16

Breast cancer is a chronic disease that is controllable, treatable, and not frightening.

Every October is Breast Cancer Awareness Month, also known as "Pink Ribbon Month." The pink ribbon is a recognized symbol of global breast cancer prevention and treatment activities, aimed at promoting early prevention, early detection, and early treatment.

2018.11.16

Breaking! Intraperitoneal hyperthermic chemotherapy can extend the life of patients with advanced ovarian cancer by one year.

Based on the secondary analysis of the Gynecologic Oncology Group (GOG) 172 and the GOG172 trial, researchers found that the survival benefits of intraperitoneal chemotherapy for patients with advanced ovarian cancer can last for at least 10 years.

< 1 2 3 4 5 > proceed page

· GDHIPEC from China ,

· Caring for Patients Worldwide ·

Tel.: +86 29 82681864

Sales service hotline: +86 15002902555

E-mail: gd029@126.com

Address: Floor 1-2, Left Building No. 1, Huoju Road, East zone of Xi’an High- tech Development District, Xi’an, China

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Internet Drug Information Service Qualification Certificate (Shaanxi)-Non-Operating -2023-0143

Blog

COOKIES

COOKIES

Sorry，The current column has no content!